BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Branco H, Oliveira J, Antunes C, Santos LL, Vasconcelos MH, Xavier CPR. Pirfenidone Sensitizes NCI-H460 Non-Small Cell Lung Cancer Cells to Paclitaxel and to a Combination of Paclitaxel with Carboplatin. Int J Mol Sci 2022;23. [PMID: 35408988 DOI: 10.3390/ijms23073631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Andreucci E, Bugatti K, Peppicelli S, Ruzzolini J, Lulli M, Calorini L, Battistini L, Zanardi F, Sartori A, Bianchini F. Nintedanib-αVβ6 Integrin Ligand Conjugates Reduce TGFβ-Induced EMT in Human Non-Small Cell Lung Cancer. Int J Mol Sci 2023;24. [PMID: 36674990 DOI: 10.3390/ijms24021475] [Reference Citation Analysis]
2 Zhang J, Zhang Y, Wang Z, Zhao J, Li Z, Wang K, Tian L, Yao B, Wu Q, Wang T, Wang J. Genes related to N6-methyladenosine in the diagnosis and prognosis of idiopathic pulmonary fibrosis. Front Genet 2022;13:1102422. [PMID: 36685949 DOI: 10.3389/fgene.2022.1102422] [Reference Citation Analysis]
3 Pérez GV, Rosales M, Ramón AC, Rodríguez-Ulloa A, Besada V, González LJ, Aguilar D, Vázquez-Blomquist D, Falcón V, Caballero E, Carvalho PC, Caldeira RS, Yang K, Perera Y, Perea SE. CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model. Biomedicines 2022;11. [PMID: 36672551 DOI: 10.3390/biomedicines11010043] [Reference Citation Analysis]
4 Nunes M, Duarte D, Vale N, Ricardo S. Pitavastatin and Ivermectin Enhance the Efficacy of Paclitaxel in Chemoresistant High-Grade Serous Carcinoma. Cancers 2022;14:4357. [DOI: 10.3390/cancers14184357] [Reference Citation Analysis]